Educational Resources

Dilon Technologies’ CoPilot VL+ video laryngoscopy system provides an excellent tool for intubating patients, especially those with suspected Covid-19 Coronavirus.

As a global provider of breast cancer solutions, Dilon's Navigator® Gamma Probes are used for radio-guided lymphatic mapping and tumor localization world-wide

“I’ve only been utilizing MarginProbe for a few weeks, and it identified a positive margin that would have been missed, in my first surgery,” stated Dr. Naik. “This enabled me to shave some additional tissue right in the OR, preventing this patient from a  second surgery and the anxiety that…

On May 2, 2019, new Georgia Governor Brian Kemp signed dense breast legislation, appropriately named “Margie’s Law”, into law. The new legislation will require all mammogram reports in the state of Georgia to inform women that they have dense breast tissue and what the implications of this finding may mean…

2019 was our busiest Breast Cancer Awareness Month ever! We supported races, attended galas and many other events all over the country in support of better breast cancer care for women and will continue to do so every day of the year!

“I always knew I wanted to be a surgeon because of the satisfaction that comes with helping others, and the immediate gratification of seeing the problem go away,” Dr. Kerry-Ann McDonald explained. “I specifically chose breast cancer surgery because it’s a field where there’s strong continuity of care."

Dr. Elizabeth Revesz has a unique background as an artist and sculptor. She was able to translate her precision, and her ability to see things in three dimensions, into a highly successful career in medicine.

Dr. Rabia Z. Bhatti with the AMITA Resurrection Medical Center has always had a strong interest in the art of surgery. “I actually love the way that patients recover,” she explained. “There’s a gratification behind treating patients and watching them get better. And after practicing general surgery for 15 years,…

“From now on, I’m going to use MarginProbe on all of my lumpectomy cases,” the Coordinated Health surgeon shared. “Somehow we have been losing control of how to use new technology to better the lives of patients and their care. That has been our battle and I think it is…

"One of the fun things about my job is that NO day is typical," Lisa explained. "I can start the day reviewing pathology reports and analyzing MarginProbe’s contribution to a surgeon’s outcomes in preparation for a data review, and then end the day by updating a training deck for our…

With 30 years in practice, Dr. Daniel Howard, a General Surgeon at Mercy Health — Lourdes Hospital, can still define exactly what attracted him to surgery. Dr. Howard’s practice at Mercy Health is the only facility in the state of Kentucky to take advantage of MarginProbe, and it’s leading the…

Every breast cancer survivor has a unique story to tell, and Alexa G is no exception. Her experience highlights the importance of patients becoming their own strongest advocate.

The Johns Hopkins Breast Center at Johns Hopkins Hospital, the #3 hospital in the U.S. News & World Report’s 2018–19 Best Hospitals list, announced that it will be adding MarginProbe® as a regular part of its program after its participation in Dilon’s MarginProbe® Post Approval Study (PAS).

Dilon Devices has reached another milestone in their MarginProbe® Post Approval Study (PAS) as Johns Hopkins Hospital and Moffitt Cancer Center complete their patient enrollments for the trial.

Dilon Devices was thrilled to host Congresswoman Lucy McBath in a recent visit to their Alpharetta office. McBath is a member of the United States House of Representatives from Georgia's 6th congressional district. Since joining Congress in January of this year, she has shown support for multiple bills seeking to…

As part of their whole-person care strategy, Dr. Wilson’s practice uses a new tool, known as MarginProbe, to ensure that a safe margin of tissue is removed around a cancerous tumor as that tumor is removed during surgery.

Dilon Devices has just completed the first in-man cases for Smart Biopsy, its percutaneous soft tissue biopsy device which leverages the real-time tissue characterization capability of its radio-frequency (RF) spectroscopy technology.

Lori Chmura and Tom Melba attended the 24th Annual Multidisciplinary Symposium on Breast Disease to exhibit MarginProbe, the only FDA approved intraoperative tool for margin assessment. Here are some of their favorite moments from the symposium.

Global breast surgeon thought leaders from the United States, Germany, Israel, the UK and Japan came together during an international investigator reception at the San Antonio Breast Cancer Symposium, hosted by Dilon.

After being awarded Medtech Woman of the Year for 2018 by MW@S, Lori joined Jason Rupp on the webinar to discuss her work with Dilon Devices, the challenges she faced as a woman in the medtech industry, and more.

Dilon CEO Lori Chmura and Chairman of the Board of Directors Amos Goren started the year off by attending the 37th Annual J.P. Morgan Healthcare Conference

With the year coming to an end we put together an overview of the many developments in breast cancer research and treatment from 2018.

The American Society of Breast Surgeons (ASBrS) united thought leaders, payment and reimbursement experts, and Industry Relations Council members to develop a strategic approach to prepare its physician members to lead enhancements in breast cancer surgery, therapeutics and technology for the future.

At the HBA: Diary of a Leader event, Lori Chmura addressed bridging the gender gap in leadership at the executive level within the healthcare industry.

“I think for breast cancer, every few months there's something new and exciting,” the physician shared. “I think there's always some new technology, new drugs, or new study that comes out that changes our outlook."

“I realized breast surgery put me in the operating room, which I love to do, but it also allowed me to take care of my patients hands-on and I could follow my patients practically forever,” explained Dr. Karen Karsif.

The team at Dilon is heartbroken over the passing of Nancy M. Cappello, Ph.D. and would like to extend sincere condolences to her family, especially her husband Joseph Cappello, friends, colleagues, and supporters.

Lori Chmura, CEO of Dilon Devices, maker of the successful MarginProbe device is scheduled to present at the Canaccord Genuity Medical Technologies and Diagnostics Forum on Thursday, November 15th at 2:30 p.m. EST at the Westin Grand Central in New York, NY.

In alignment with their mission to ensure that every woman with a diagnosis of breast cancer has an opportunity to receive the most comprehensive care possible, Dilon recently sponsored SHARE at their annual tasting benefit night, A Second Helping of Life.

Dr. Jeffrey Falk, board certified Surgical Oncologist at St Johns Hospital in Detroit, recently shared his outstanding results reducing positive margin rates using MarginProbe in lumpectomy at ORBS by Design 2018.

Breast density is one of the most common reasons for failure of mammography to detect cancer and presents unique challenges for breast cancer patients and providers. Despite being a well-established independent risk factor for breast cancer(1), 95% of women do not know their breast density.

There has been much recent discussion around breast cancer in areas of breast density in relation to detection, and the latest observations in the field of genetics. A veteran breast surgeon, Dr. Erica Giblin, took some time to share her thoughts on the impact of both.

Capitalizing on the European Union Horizon 2020 research and innovation program, Dilon has completed the first phase in the development of its percutaneous soft tissue biopsy device.

It’s been one year since our relocation to Atlanta in August 2017. We have been incredibly busy these past 12 months, and here are some of the highlights!

Tidelands Health Breast Center uses the latest technological developments, such as MarginProbe, to refine and improve their surgical outcomes.

A strong association between re-excision surgery and reduced patient satisfaction scores is one of the many reasons that removing all of the cancerous tissue in the patient’s first surgery is so important to a successful outcome.

Dr. Daniel Barnas shares his thoughts here on how to build and nurture strong patient relationships while ensuring the best physical and cosmetic outcomes throughout the breast cancer treatment journey.

Dr. Alice Police has been a surgeon for 30 years and is a pioneer in her field, having founded her own breast treatment center and currently holding the position of Regional Director of Breast Surgery for Northwell Health in Westchester County, NY.

A study recently published in the American Journal of Surgery demonstrates that proper use of Dilon Devices’ intraoperative margin assessment device, MarginProbe, results in a significant identification of positive margins and a resulting reduction in the re-excision rate for breast conserving surgery - the standard option for patients with early-stage…

Dr. Beth Anglin is a breast cancer surgeon with almost 20 years of experience and a unique expertise on the genes responsible for many breast cancer cases: BRCA1 and BRCA2. These are the most common genes involved in hereditary breast and ovarian cancers, and the surgeon recently related that out…

With sustainability in mind, Dune designed a reposable version of MarginProbe. The new reposable MarginProbe has a reusable cable and handle and a single-use attachable probe. The new probe has the potential to reduce waste burden of MarginProbe up to 50%.

Dr. Jennifer Simmons has a very personal connection to breast cancer - a family member was diagnosed at only 29 years old, dying from the disease at 36. “Breast cancer was very much a part of my childhood and I understood at a very early age the impact that it…

With over 2 decades of surgical experience, Dr. Rhonda Wachsmuth leads an all-woman practice, maintaining a crisp focus on breast disease. She has pioneered many of the treatments that have dramatically reduced the need for invasive breast surgeries.

Calvin Ridgeway, M.D., is a surgical oncologist specializing in breast cancer care. He began his career as a surgical oncologist for the United States Air force at Kirtland Air Force Base in Albuquerque and in 2008 joined Lovelace Women’s Hospital to start their breast care center - the first accredited…

June 12, 2018 (Alpharetta, Ga.) Dilon Devices has appointed Avihai Lachman as Vice President of Research and Development, leading the company’s effort in expanding the use of Radio Frequency (RF) Spectroscopy for new clinical applications and disease sites. Lachman joins Dune after more than a decade of developing radio frequency…

Medtech Innovator Dilon Devices to present at Jefferies 2018 Global Healthcare Conference ATLANTA, Ga - -Lori Chmura, CEO of Dilon Devices, maker of the successful MarginProbe device, will address investors at the Jefferies Global Healthcare Conference on June 8th, 12.30 ET. The presentation will also be available as a webcast…

The Atlanta Business Chronicle has named Dilon Device’s Lori Chmura as a finalist for Health Care Innovator/Researcher in their 2018 Health Care Heroes Awards. These awards aim to highlight the individuals and companies that are dedicated to improving the overall health and well-being of the community. This is the publication’s…

May 17, 2018 (Alpharetta, Ga.) Dilon Devices has appointed Alan Bond as Chief Financial Officer. Bond is a veteran financial executive with an extensive record of developing and implementing strategy, and driving revenue and profitability in the medical device industry. Bond joins the Dune Atlanta office after years with McKesson…

A study recently published in the American Journal of Surgery demonstrates that proper use of Dilon Devices’ intraoperative margin assessment device, MarginProbe, results in a significant identification of positive margins and a resulting reduction in the re-excision rate for breast conserving surgery - the standard option for patients with early-stage…

About the American Society of Breast Surgeons (ASBrS) In the organization’s own words, “The American Society of Breast Surgeons, the primary leadership organization for general surgeons who treat patients with breast disease, is committed to continually improving the practice of breast surgery by serving as an advocate for surgeons who…